Evonik and Asiga collaborate on photopolymer-based 3D printing for large-scale industrial manufacturing, said the company.
The specialty chemicals company Evonik and Australia’s 3D printer manufacturer Asiga are strengthening their collaboration in photopolymer-based 3D printing. Both companies aim to drive forward 3D printing large-scale industrial manufacturing by extending today’s capabilities of photo-curing technologies. Evonik is contributing its expertise in development and manufacturing of ready-to-use photopolymer materials. Asiga, in turn, is bringing its innovative strength in DLP 3D printers with their open material architecture to the joint effort.
Evonik’s new INFINAM photopolymers are ready-to-use high-performance formulations that can be processed seamlessly on Asiga’s DLP 3D printers.
Asiga is an innovation driver in desktop stereolithography, launching the world's first LED based DLP 3D printer in 2011. Today the company continues to focus on a range of process monitoring technologies which control part accuracy and production stability across many industries including medical and general manufacturing. Asiga's product line covers a broad range from powerful desktop 3D printers including their MAX series to large format floor standing such as the PRO 4K.
Last year, Evonik introduced first ready-to-use formulations of its new photopolymers product line for industrial 3D printing applications. INFINAM® TI 3100 L leads to high toughness and impact-resistant 3D parts which can withstand strong impact or permanent mechanical effects such as pressing or impact. INFINAM® ST 6100 L is setting-up a new benchmark in the category of high strength polymer resins. It combines tensile strength of 89 MPa, flexural strength of 145 MPa and HDT of 120 °C, and thus fills the material gap in ultra-high strength photopolymers. INFINAM® RG 3101 L combines excellent impact resistance with high-temperature resistance while exhibiting long-lasting thermomechanical performance.
Evonik’s 3D printing activities are bundled in the group’s additive manufacturing innovation growth field. The strategic focus is on the development and manufacturing industrial ready-to-use high-performance materials for all major polymer-based 3D-printing technologies. The specialty chemicals company thus drives 3D printing as a large-scale industrial manufacturing technology along the entire value chain. In this context, Evonik has organized its product range under the new INFINAM brand.
As MRC reported before, Evonik is investing a three-digit million-euro sum in the construction of a new production plant for bio-based and fully biodegradable rhamnolipids. The decision to build the plant follows a breakthrough in Evonik's research and development. Rhamnolipids are biosurfactants and serve as active ingredients in shower gels and detergents. Demand for environ-mentally friendly surfactants is growing rapidly worldwide.
We remind that in February, 2020, Dow and Evonik entered into an exclusive technology partnership. Together, they plan to bring a unique method for directly synthesizing propylene glycol (PG) from propylene and hydrogen peroxide to market maturity.
Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of EUR12.2 billion and an operating profit (adjusted EBITDA) of EUR1.91 billion in 2020. Evonik goes far beyond chemistry to create innovative, profitable and sustainable solutions for customers. About 33,000 employees work together for a common purpose: to improve life today and tomorrow.
mrchub.com